Archive for the ‘
Uncategorized ’ Category
Friday, October 2nd, 2009
This is a short review today, folks, as most of last week was spent at our Pharmaceutical Marketing and Media Conference in Princeton and this week I am actually off. I've been in Boston since Tuesday for some vacation and upcoming sitdowns with people at the Novartis Institutes of Biomedical ...
Posted in
Uncategorized |
No Comments »
Friday, September 18th, 2009
Yes, I took some time off from the roundup, as two magazines had to get out the door here (and there was also the Labor Day weekend holiday to get through). But what a time to get back on track again: on Monday, Lilly announced that it would be dumping ...
Posted in
Uncategorized |
No Comments »
Friday, August 21st, 2009
It was definitely a slower news week in the pharma arena, as many people have gone on vacation. But there was news to be found. Pharmaceutical ghostwriting got spotlighted again, as court documents obtained by the Associated Press showed GlaxoSmithKline had its own program, called CASPPER, for Paxil (and indeed ...
Posted in
Uncategorized |
No Comments »
Friday, August 14th, 2009
This week, the big news items included FDA giving notice that it was going to be tougher about disqualifying noncompliant investigators in clinical trials of drugs and medical devices; FDA's Dr. Janet Woodcock was accused of conflict-of-interest by one generic pharmaceutical company, which said she gave another generic pharmaceutical company ...
Posted in
Uncategorized |
No Comments »
Thursday, August 6th, 2009
What a week. Who said the summer time can be slow? Eli Lilly announced plans to offer buyouts to more than 4,000 sales reps; animal rights activitists reportedly set fire to the vacation home of Novartis CEO Daniel Vasella, stole the ashes from his mother's grave, and did more vandalism ...
Posted in
Uncategorized |
No Comments »
Friday, July 31st, 2009
This week was still all about healthcare reform as legislators frantically try to pass something – anything, it seems – before the break. In other pharma/healthcare topics that had some bloggers abuzz, the Senate Special Committee on Aging heard testimony about whether pharmaceutical industry support of continuing medical education was ...
Posted in
Uncategorized |
No Comments »
|
|
